BeStock  
Stocks › ARWR

Arrowhead Pharmaceuticals ARWR

US equityMarket cap rank #1888
$41.37 −$2.28 (-5.22%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $41.40 +0.07%
Open$43.15
Prev close$43.65
Day range$41.17 – $44.80
Volume3.91M
Market cap$5.85B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±9.7%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+24.2%
Worst reaction-26.8%

Stock move on the day after each report

-26.8%2023/Q4-10.7%2024/Q2-9.4%2024/Q3+24.2%2024/Q4-5.2%2025/Q1+9.4%2025/Q2+2.2%2025/Q3+23.3%2025/Q4-0.2%2026/Q1-6.7%2026/Q2-3.0%2026/Q3+1.3%2026/Q4
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q412 Nov 2026After Market±8.5%+1.34%Within range
2026/Q34 Aug 2026After Market±8.9%-2.99%Within range
2026/Q27 May 2026After Market±7.3%-6.75%Within range
2026/Q15 Feb 2026After Market±11.9%-0.19%Within range
2025/Q425 Nov 2025After Market±13.5%+23.34%Bigger than priced
2025/Q37 Aug 2025After Market±13.3%+2.24%Within range
2025/Q212 May 2025After Market±12.0%+9.38%Within range
2025/Q110 Feb 2025After Market±10.8%-5.17%Within range
2024/Q426 Nov 2024After Market±15.0%+24.23%Bigger than priced
2024/Q38 Aug 2024After Market±12.7%-9.44%Within range
2024/Q29 May 2024After Market±10.4%-10.68%Bigger than priced
2023/Q429 Nov 2023After Market±12.0%-26.85%Bigger than priced
2023/Q37 Aug 2023After Market±8.9%-10.78%Bigger than priced
2023/Q22 May 2023After Market±16.4%+13.62%Within range
2023/Q16 Feb 2023After Market±14.3%+0.33%Within range
2022/Q428 Nov 2022After Market±20.5%+7.11%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q4, ended Sep 2026

Revenue$37.79M-85.3% YoY
Operating profit-$436.63M-1,089.9% YoY
Net profit-$428.89M-2,760.4% YoY
Diluted EPS-$3.01-1,572.2% YoY
Free cash flow-$195.83M-1,606.2% YoY
Operating cash flow-$192.40M

Revenue, last 8 quarters

$2.5MDec '24$542.7MMar '25$27.8MJun '25$256.5MSep '25$264.0MDec '25$73.7MMar '26$75.3MJun '26$37.8MSep '26

Net profit, last 8 quarters

$-175.2MDec '24$367.9MMar '25$-178.7MJun '25$16.1MSep '25$28.2MDec '25$-137.6MMar '26$-178.9MJun '26$-428.9MSep '26

Profitability & balance sheet

Gross margin99.6%
Operating margin-156.9%
Net margin-160.6%
Return on equity-280.5%
Return on assets-46.4%
Return on invested capital-73.2%
Current ratio4.14
Liabilities / assets97.1%
Cash & investments$1.19B
Total debt$994.70M
Net cash (debt)$198.29M

Discussion

No comments yet — be the first to weigh in on ARWR.

Sign in to join the discussion.

Scroll to Top